Synapse - Gopakumar Iyer

Search Within

Gopakumar Vasudeva Iyer

Results (342)

Molecular results and potential biomarkers identified from the phase 3 MILO/ENGOT-ov11 study of binimetinib versus physician choice of chemotherapy in recurrent low-grade serous ovarian cancer

Journal Article

Grisham, R. N.; Vergote, I.; Banerjee, S.; Drill, E.; Kalbacher, E.; Mirza, M. R.; Romero, I.; Vuylsteke, P.; Coleman, R. L.; Hilpert, F.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Integration of peripheral blood- and tissue-based biomarkers of response to immune checkpoint blockade in urothelial carcinoma

Journal Article

Vanguri, R. S.; Smithy, J. W.; Li, Y.; Zhuang, M.; Maher, C. A.; Aleynick, N.; Peng, X.; Al-Ahmadie, H.; Funt, S. A.; Rosenberg, J. E.; more...
Journal of Pathology (2023)

Fulltext@MSK | Save

An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC)

Meeting Abstract

Dsouza, N.; Gaffney, C.; Hernandez, C.; Moran, P.; Worth, K.; McCarter, M.; de Jesus, M. R.; Solit, D. B.; Sarungbam, J.; Al-Ahmadie, H. A.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Phase 2, multicenter, open-label basket trial of nab -sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I)

Meeting Abstract

Iyer, G.; Deming, D. A.; Demeure, M. J.; Federman, N.; McKean, M.; Lee, E. K.; Spira, A. I.; Kwiatkowski, D. J.; Hussein, M. A.; Gordon, E. M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB)

Meeting Abstract

Guercio, B. J.; Ratna, N.; Gavrilov, D.; Duzgol, C.; Akhlaq, M.; Teo, M. Y.; Regazzi, A. M.; Kotecha, R. R.; Funt, S. A.; Aggen, D. H.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository

Meeting Abstract

Choudhury, N. J.; Harada, G.; Whiting, K.; Shen, R.; Yang, S. R.; Solit, D. B.; Berger, M. F.; Dinapoli, S.; Abou-Alfa, G. K.; Iyer, G.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Tumor agnostic efficacy and safety of erdafitinib (erda) in patients (pts) with advanced solid tumors with prespecified FGFR alterations (FGFRalt): RAGNAR primary analysis

Meeting Abstract

Pant, S.; Schuler, M. H.; Iyer, G.; Witt, O.; Doi, T.; Qin, S.; Tabernero, J.; Reardon, D. A.; Massard, C.; Welsh, L.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): An international, single-arm, phase 2 study

Journal Article

Pant, S.; Schuler, M.; Iyer, G.; Witt, O.; Doi, T.; Qin, S.; Tabernero, J.; Reardon, D. A.; Massard, C.; Minchom, A.; more...
Lancet Oncology (2023)

Fulltext@MSK | Save

Hypofractionated radiation therapy (Hypo-RT) for the treatment of localized bladder cancer

Journal Article

Moore, A.; Lobaugh, S. M.; Zhang, Z.; Rosenberg, J. E.; Iyer, G.; Teo, M. Y.; Bochner, B.; Donahue, T.; Nunez, D. A.; Dreyfuss, A.; more...
Bladder Cancer (2023)

Fulltext@MSK | Save

Genomic landscape of upper tract urothelial carcinoma and its histologic subtypes

Meeting Abstract

Nezami, B.; Alghamdi, M.; Katims, A.; Chen, J. F.; Sarungbam, J.; Sirintrapun, S. J.; Gopalan, A.; Chen, Y. B.; Fine, S.; Iyer, G.; more...
Laboratory Investigation (2023)

Fulltext@MSK | Save